|
My onc drew a graph to show me the difference in recurrence rates in the "normal" breast cancer population and her2+ cancers treated with herceptin. He stated that the "normal" rate of recurrence runs fairly level for the first five years then begins to gradually drop off. With her2+ treated with herceptin, the rate of recurrence runs fairly level at the same rate as the "normal" population for about TWO years, then drops off DRAMATICALLY. I asked if this was based on the four years of studies and he said it includes some for five years.
This would concur with what Alaska says she has been told about her2+ recurrence.
Sassy
|